These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25072620)
41. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Zerr DM; Corey L; Kim HW; Huang ML; Nguy L; Boeckh M Clin Infect Dis; 2005 Apr; 40(7):932-40. PubMed ID: 15824982 [TBL] [Abstract][Full Text] [Related]
42. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748 [TBL] [Abstract][Full Text] [Related]
43. Cord blood transplantation in Western Australia. Purtill D; Cooney J; Cannell P; Herrmann R; Trimboli F; Carter T; Baker D; Cole C Intern Med J; 2012 Sep; 42(9):1008-13. PubMed ID: 21981267 [TBL] [Abstract][Full Text] [Related]
44. Haploidentical cord transplantation-The best of both worlds. van Besien K; Childs R Semin Hematol; 2016 Oct; 53(4):257-266. PubMed ID: 27788764 [TBL] [Abstract][Full Text] [Related]
45. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Sanz J; Montesinos P; Saavedra S; Lorenzo I; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Martinez D; Gómez I; López M; Sanz MA; Sanz GF Biol Blood Marrow Transplant; 2010 Nov; 16(11):1589-95. PubMed ID: 20553927 [TBL] [Abstract][Full Text] [Related]
46. Ex vivo expansion of umbilical cord blood for transplantation. Tung SS; Parmar S; Robinson SN; De Lima M; Shpall EJ Best Pract Res Clin Haematol; 2010 Jun; 23(2):245-57. PubMed ID: 20837337 [TBL] [Abstract][Full Text] [Related]
47. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Wang LR; Dong LJ; Zhang MJ; Lu DP Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666 [TBL] [Abstract][Full Text] [Related]
48. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation. Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983 [TBL] [Abstract][Full Text] [Related]
49. Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan. Kai S; Wake A; Okada M; Kurata M; Atsuta Y; Ishikawa J; Nakamae H; Aotsuka N; Kasai M; Misawa M; Taniguchi S; Kato S Biol Blood Marrow Transplant; 2013 May; 19(5):812-9. PubMed ID: 23416856 [TBL] [Abstract][Full Text] [Related]
50. Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience From Hong Kong. Tsang KS; Leung AW; Lee V; Cheng FW; Shing MM; Pong HN; Leung TF; Yuen PM; Li CK Cell Transplant; 2016; 25(7):1277-86. PubMed ID: 26432454 [TBL] [Abstract][Full Text] [Related]
51. Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies. Mori T; Tanaka M; Kobayashi T; Ohashi K; Fujisawa S; Yokota A; Fujita H; Nakaseko C; Sakura T; Nannya Y; Takahashi S; Kanamori H; Kanda Y; Sakamaki H; Okamoto S; Biol Blood Marrow Transplant; 2013 Mar; 19(3):486-91. PubMed ID: 23253560 [TBL] [Abstract][Full Text] [Related]
52. The role of HLA in umbilical cord blood transplantation. Delaney M; Ballen KK Best Pract Res Clin Haematol; 2010 Jun; 23(2):179-87. PubMed ID: 20837329 [TBL] [Abstract][Full Text] [Related]
53. Umbilical cord blood transplantation--how, when and for whom? Cohen Y; Nagler A Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901 [TBL] [Abstract][Full Text] [Related]
54. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Sobol U; Go A; Kliethermes S; Bufalino S; Rodriguez T; Smith S; Parthasarathy M; Stiff P Bone Marrow Transplant; 2015 Dec; 50(12):1519-25. PubMed ID: 26367229 [TBL] [Abstract][Full Text] [Related]
55. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation. Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061 [TBL] [Abstract][Full Text] [Related]
56. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691 [TBL] [Abstract][Full Text] [Related]
57. Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Católica de Chile. Ramirez P; Nervi B; Bertin P; Poggi H; Lagos M; Selman C; Pizarro I; Jara V; Wiestruck A; Barriga F Transplant Proc; 2013; 45(10):3734-9. PubMed ID: 24315012 [TBL] [Abstract][Full Text] [Related]
58. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen. Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822 [TBL] [Abstract][Full Text] [Related]